SUMMARY A 47-year-old factor VIII deficient haemophiliac successfully underwent bilateral cataract extraction. The use of cryoprecipitates to achieve haemostasis permitted retrobulbar anaesthesia and a peripheral iridectomy without complication. We consider that the use of cryoprecipitated factor VIII concentrate allows safe elective ocular surgery in patients with classic haemophilia.
The danger of haemorrhage in patients with haemophilia has necessitated postponement of elective ocular surgery or the use of special techniques to avoid untoward bleeding. The advent of cryoprecipitated factor VIII concentrate prepared from human plasma has made possible the restoration of normal haemostasis for the entire operative period. Elective ocular surgery can then be performed with the usual techniques. We wish to describe a patient with classic haemophilia who underwent bilateral cataract surgery by means of retrobulbar anaesthesia and peripheral iridectomies, a procedure not previously described in these patients.
Case report
A 47-year-old male watchmaker was a known haemophiliac since childhood. He had noted steadily decreasing vision in both eyes for the past year. On admission he had visual acuity of hand movements only in both eyes, with normal light projection, 2-point discrimination, and colour perception. Mature cataracts in both eyes prevented fundus examination. Intraocular pressures were normal.
General physical examination was normal. Laboratory findings are shown in Table 1 At examination 10 weeks later the patient had 6/9 vision with his aphakic correction, but complained of difficulty working as a watchmaker because of the absence of binocular vision. He therefore was readmitted for cataract extraction in his left eye.
Preoperatively the factor VIII level was now found to be 7-5%. The other pertinent tests were not significantly different from those shown in Table 1 . 
Discussion
The introduction of cryoprecipitates made it practicable for blood banks to produce factor VIII in concentrated form at a reasonable cost (Pool et al., 1964) . The use of this concentrate is now standard in the treatment of classic haemophilia (Dallman and Pool, 1968) . Despite this, ophthalmic surgeons continue to use special precautions in cataract extractions in these patients, such as general anaesthesia and omission of iridectomy (Osterlind and Nilsson, 1968; Strauss and Ramsell, 1968; Richards and Spurling, 1973) .
Before the introduction of factor VIII concentrates, prolonged bleeding after ocular surgery was a dreaded complication (Rubinstein et al., 1966) . The occurrence of a retrobulbar haemorrhage could lead to permanent visual loss (Zimmerman and Merigan, 1960) . Surgical procedures were to be avoided if possible (Rubinstein et al., 1966) . However, since the introduction of cryoprecipitated factor VIII concentrate the approach to elective general surgery has changed (Cooke et al., 1968) . We therefore felt justified in attempting cataract extraction in our patient using our standard operating procedure while replacing his deficient clotting factor in the manner outlined by Richards and Spurling (1973) . Our only modification was in the use of a corneal section because of the rare occurrence of a hyphaema even months after surgery due to focal vascularisation of limbal wounds (Swan, 1973) . In a haemophiliac such bleeding into the eye would be especially hazardous.
It is worthwhile to note that our patient had what is considered mild haemophilia with factor VIII levels between 7 5 % and 10%. These levels uncommonly cause spontaneous bleeding but are associated with severe and unsuspected bleeding at surgery. Levels of factor VIII activity of at least 25% are generally regarded as necessary to prevent surgical complications (Wintrobe, 1974) . Because of the good results in our patient we feel encouraged to attempt such an approach in other haemophiliacs who until now were discouraged from undergoing elective ocular surgery. This becomes especially meaningful as the life expectancy of haemophiliacs continues to increase with the availability of effective therapeutic materials.
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